Search hospitals > Washington > Wenatchee
Wenatchee Valley Medical Center
Claim this profileWenatchee, Washington 98801
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Lymphoma
Conducts research for Leukemia
235 reported clinical trials
8 medical researchers
Summary
Wenatchee Valley Medical Center is a medical facility located in Wenatchee, Washington. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Lymphoma, Leukemia and other specialties. Wenatchee Valley Medical Center is involved with conducting 235 clinical trials across 359 conditions. There are 8 research doctors associated with this hospital, such as Rafael Santana-Davila, MD, Anton Grasch, MD, Heidi J. Gray, and Cristina P Rodriguez.Area of expertise
1Cancer
Global LeaderStage II
Stage III
Stage IV
2Breast Cancer
Global LeaderHER2 negative
ER positive
PR positive
Top PIs
Rafael Santana-Davila, MDSeattle Cancer Care Alliance5 years of reported clinical research
Studies Cancer
Studies Non-Small Cell Lung Cancer
7 reported clinical trials
13 drugs studied
Anton Grasch, MDCentral Washington Health Services Association d/b/a Confluence Health4 years of reported clinical research
Studies Colorectal Cancer
Studies Type 2 Diabetes
9 reported clinical trials
10 drugs studied
Heidi J. GrayFred Hutchinson Cancer Research Center7 years of reported clinical research
Studies Adenocarcinoma
Studies Ovarian Cancer
6 reported clinical trials
14 drugs studied
Cristina P RodriguezSeattle Cancer Care Alliance / University of Washington2 years of reported clinical research
Studies Cancer
Studies Squamous Cell Carcinoma
6 reported clinical trials
14 drugs studied
Clinical Trials running at Wenatchee Valley Medical Center
Non-Small Cell Lung Cancer
Lung Cancer
Obesity
Squamous Cell Carcinoma
Cardiovascular Disease
Oropharyngeal Carcinoma
Cancer
ALK Gene Rearrangement
Colorectal Cancer
Laryngeal Squamous Cell Carcinoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Ponsegromab
for Cachexia
This trial tests Ponsegromab, a new drug, on cancer patients who are losing weight and have high GDF 15 levels. The drug aims to lower GDF 15 to improve appetite and reduce weight loss.
Recruiting0 awards Phase 210 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Wenatchee Valley Medical Center?
Wenatchee Valley Medical Center is a medical facility located in Wenatchee, Washington. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Lymphoma, Leukemia and other specialties. Wenatchee Valley Medical Center is involved with conducting 235 clinical trials across 359 conditions. There are 8 research doctors associated with this hospital, such as Rafael Santana-Davila, MD, Anton Grasch, MD, Heidi J. Gray, and Cristina P Rodriguez.